Navigation
Navigation

Capricorn Health-tech Fund

The Capricorn Health-tech Fund (CHF) focuses on human health-technology investments. Health-technologies relate to the prevention, the diagnosis and the treatment of diseases.

New study presents impressive results of Nexstim SmartFocus® nTMS Language Mapping

News
- 13/01/2021
Helsinki, Finland: 13 January 2021 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) announces that a new study published in Cancers in January presents impressive results of nTMS language mapping in a large amount of patients. Using the…
Read more

Nexstim has received three new NBS System orders

News
- 22/12/2020
Helsinki, Finland: 22 December 2020 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) announces that it has received three new NBS system orders in December. One purchase order came from a new neurosurgical customer in Spain. Two other…
Read more

Team
Dr Jos B. Peeters
Chairman Executive Committee - Venture Capital, IT
Dr Katya Smirnyagina
Executive Director Capricorn Health-tech Fund

Portfolio

Success stories

Ogeda

Ogeda [Belgium] is a drug development company with a chemistry service business focusing on discovery of small molecules targeting GPCRs.